Health
Arthritis drug Tocilizumab reduces severe Covid mortality: study – Bangkok Post
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts…
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given…
-
General19 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General22 hours agoRestaurants on the brink as business failures plateau
-
General18 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General20 hours agoChina says Donald Trump’s Golden Dome plans risk weaponising space